Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts-Reference-Cited by-同舟云学术

Soluble levels of CD27 and CD30 are associated with risk of non-Hodgkin lymphoma in three Chinese prospective cohorts

Published:2015-06-26 Issue:11 Volume:137 Page:2688-2695
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Bassig Bryan A.¹,Shu Xiao-Ou²,Koh Woon-Puay³,Gao Yu-Tang⁴,Purdue Mark P.⁵,Butler Lesley M.⁶⁷,Adams-Haduch Jennifer⁶,Xiang Yong-Bing⁸,Kemp Troy J.⁹,Wang Renwei⁶,Pinto Ligia A.⁹,Zheng Tongzhang¹⁰,Ji Bu-Tian¹,Hosgood H. Dean¹¹,Hu Wei¹,Yang Gong²,Zhang Heping¹⁰,Chow Wong-Ho¹²,Kim Christopher¹,Seow Wei Jie¹,Zheng Wei²,Yuan Jian-Min⁶⁷,Lan Qing¹,Rothman Nathaniel¹

Affiliation:

1. Division of Cancer Epidemiology and Genetics; National Cancer Institute; Rockville MD

2. Division of Epidemiology, Vanderbilt Epidemiology Center; Vanderbilt University School of Medicine; Nashville TN USA

3. Duke-NUS Graduate Medical School Singapore; Singapore

4. Department of Epidemiology; Shanghai Cancer Institute, Shanghai Jiaotong University; Shanghai China

5. Ontario Institute for Cancer Research; Toronto ON Canada

6. Division of Cancer Control and Population Sciences; University of Pittsburgh Cancer Institute; Pittsburgh PA

7. Department of Epidemiology; Graduate School of Public Health, University of Pittsburgh; PA

8. Shanghai Cancer Institute, Renji Hospital, Shanghai Jiaotong University School of Medicine; Shanghai China

9. HPV Immunology Laboratory; Leidos Biomedical Research Inc., Frederick National Laboratory for Cancer Research; Frederick MD

10. Yale University School of Public Health; New Haven CT

11. Department of Epidemiology and Population Health; Albert Einstein College of Medicine; NY

12. Department of Epidemiology; The University of Texas MD Anderson Cancer Center; Houston TX

Funder

United States National Institutes of Health

National Institutes of Health

Intramural Research Program of the National Institutes of Health, National Cancer Institute

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference26 articles.

1. Altered immunity as a risk factor for non-Hodgkin lymphoma;Grulich;Cancer Epidemiol Biomarkers Prev,2007

2. Current understanding of lifestyle and environmental factors and risk of non-hodgkin lymphoma: an epidemiological update;Bassig;J Cancer Epidemiol,2012

3. A prospective study of 67 serum immune and inflammation markers and risk of non-Hodgkin lymphoma;Purdue;Blood,2013

4. Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma;Purdue;Cancer Res,2011

5. Plasma cytokines and future risk of non-Hodgkin lymphoma (NHL): a case-control study nested in the Italian European Prospective Investigation into Cancer and Nutrition;Saberi Hosnijeh;Cancer Epidemiol Biomarkers Prev,2010

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immune checkpoints represent a promising breakthrough in targeted therapy and prognosis of myelodysplastic syndrome;Heliyon;2023-09

2. Longitudinal Changes in Immune Activation Serum Biomarkers Prior to Diagnosis and Risk of B-cell NHL Subtypes;Cancer Epidemiology, Biomarkers & Prevention;2022-11-21

3. Circulating immune markers and risks of non‐Hodgkin lymphoma subtypes: A pooled analysis;International Journal of Cancer;2022-10-05

4. Erythrocyte levels of cadmium and lead and risk of B ‐cell non‐Hodgkin lymphoma and multiple myeloma;International Journal of Cancer;2020-06-25

5. Prediagnostic serum sCD27 and sCD30 in serial samples and risks of non‐Hodgkin lymphoma subtypes;International Journal of Cancer;2019-10-11